RARRES2 and neoplasm: The majority of present data report down-regulation of chemerin in cancer tissue and suggest a tumor-suppressing role of chemerin in most cancer entities, being mediated by recruiting innate immune defenses and by growth-inhibitory downstream signaling by chemerin receptors CMKLR1 and GPR1.